SCHEMBL6681649

SCHEMBL6681649

CN(C)CC1CC/C(=C/c2cccc(C(=O)O)c2)C=C1c1cccc(O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.38
CCR6 P51684 1/20 0.38
P4HB P07237 1/20 0.38
MITF O75030 1/20 0.37
TTR P02766 3/20 0.36
HSD17B1 P14061 3/20 0.36
HSD17B2 P37059 3/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA6 P23280 1/20 0.36
CA9 Q16790 1/20 0.36
OPRK1 P41145 1/20 0.35
SRD5A1 P18405 1/20 0.35
UNG P13051 1/20 0.34
OPRD1 P41143 1/20 0.33
MCHR1 Q99705 1/20 0.33
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6680252 1.00 HSP90AA1 (0.38) HSP90AA1CCR6P4HBMITFTTR
SCHEMBL6678554 1.00 HSP90AA1 (0.38) HSP90AA1CCR6P4HBMITFTTR
Hydrochloric Acid SCHEMBL6721153 0.99 HSP90AA1 (0.40) HSP90AA1CCR6P4HBMITFTTR
Hydrochloric Acid SCHEMBL6721152 0.99 HSP90AA1 (0.40) HSP90AA1CCR6P4HBMITFTTR
SCHEMBL6678900 0.90 P4HB (0.42) HSP90AA1CCR6P4HBMITFHSD17B1
SCHEMBL6678902 0.90 P4HB (0.42) HSP90AA1CCR6P4HBMITFHSD17B1
SCHEMBL6679108 0.90 P4HB (0.42) HSP90AA1CCR6P4HBMITFHSD17B1
Hydrochloric Acid SCHEMBL6716303 0.89 HSP90AA1 (0.42) HSP90AA1CCR6P4HBMITFHSD17B1
Hydrochloric Acid SCHEMBL6716562 0.89 HSP90AA1 (0.42) HSP90AA1CCR6P4HBMITFHSD17B1
Hydrochloric Acid SCHEMBL6716297 0.89 HSP90AA1 (0.42) HSP90AA1CCR6P4HBMITFHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246793-B1 SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2004-11-10 EP disclosed
US-6673794-B2 ANALGESICS, INCOTINENCE, SKIN DISORDERS, ANTIINFLAMMATORY AGENTS GRUENENTHAL GMBH (DE) 2004-01-06 US disclosed
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives GRUENETHAL GMBH (DE) 2003-04-10 US disclosed
EP-1246793-A2 SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2002-10-09 EP disclosed
WO-2001049654-A2 SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2001-07-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069288-A1 Substituted aminomethyl-phenyl-cyclohexane derivatives PTGER1, CYP2E1, HRH2 HSP90AA1 1652/4885CCR6 1317/4885P4HB 2142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.